{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:56:40Z","timestamp":1769975800775,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.diabres.2018.07.035","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T18:12:04Z","timestamp":1533233524000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey"],"prefix":"10.1016","volume":"144","author":[{"given":"Nadine","family":"Taleb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Messier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Ott-Braschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Ardilouze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.diabres.2018.07.035_b0005","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1001\/archinte.161.19.2293","article-title":"Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy","volume":"161","author":"Lenhard","year":"2001","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.diabres.2018.07.035_b0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/17425247.2016.1115013","article-title":"Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons","volume":"13","author":"Thabit","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.diabres.2018.07.035_b0015","doi-asserted-by":"crossref","unstructured":"Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. The Cochrane database of systematic reviews. 2010(1):CD005103.","DOI":"10.1002\/14651858.CD005103.pub2"},{"issue":"17","key":"10.1016\/j.diabres.2018.07.035_b0020","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMct1113948","article-title":"Insulin-pump therapy for type 1 diabetes mellitus","volume":"366","author":"Pickup","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.diabres.2018.07.035_b0025","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/dc16-2201","article-title":"Glycemic control during continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: individual patient data meta-analysis and meta-regression of randomized controlled trials","volume":"40","author":"Pickup","year":"2017","journal-title":"Diabetes Care"},{"issue":"9950","key":"10.1016\/j.diabres.2018.07.035_b0030","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(14)61037-0","article-title":"Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial","volume":"384","author":"Reznik","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.diabres.2018.07.035_b0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2337\/diacare.25.3.593","article-title":"Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes","volume":"25","author":"Pickup","year":"2002","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2018.07.035_b0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-8587(16)30280-7","article-title":"Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial","volume":"5","author":"Thabit","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.diabres.2018.07.035_b0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1262-3636(07)70281-1","article-title":"Technical risks with subcutaneous insulin infusion","volume":"32","author":"Guilhem","year":"2006","journal-title":"Diabetes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2018.07.035_b0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/0145721716642526","article-title":"Improving patient experience with insulin infusion sets: practical guidelines and future directions","volume":"42","author":"Evert","year":"2016","journal-title":"Diabetes Educ"},{"issue":"6","key":"10.1016\/j.diabres.2018.07.035_b0055","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00592-015-0784-2","article-title":"Clinical review: insulin pump-associated adverse events in adults and children","volume":"52","author":"Ross","year":"2015","journal-title":"Acta Diabetol"},{"issue":"23","key":"10.1016\/j.diabres.2018.07.035_b0060","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1001\/jama.1984.03350230025026","article-title":"Acute complications associated with insulin infusion pump therapy. report of experience with 161 patients","volume":"252","author":"Mecklenburg","year":"1984","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.diabres.2018.07.035_b0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2337\/diacare.9.4.351","article-title":"Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients","volume":"9","author":"Mecklenburg","year":"1986","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2018.07.035_b0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1089\/dia.2013.0388","article-title":"Insulin pump-associated adverse events in children and adolescents\u2013a prospective study","volume":"16","author":"Wheeler","year":"2014","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.diabres.2018.07.035_b0075","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2337\/dc15-0168","volume":"38","author":"Heinemann","year":"2015","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2018.07.035_b0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/dia.2013.0192","article-title":"Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey","volume":"16","author":"Pickup","year":"2014","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2018.07.035_b0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.35680\/2372-0247.1064","article-title":"Patient partnership in quality improvement of healthcare services: patient's inputs and challenges faced","volume":"2","author":"Marie-Pascale Pomey","year":"2015","journal-title":"Patient Experience J"},{"issue":"7","key":"10.1016\/j.diabres.2018.07.035_b0090","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1464-5491.2008.02486.x","article-title":"Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion","volume":"25","author":"Pickup","year":"2008","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.diabres.2018.07.035_b0095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-157-5-201209040-00508","article-title":"Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis","volume":"157","author":"Yeh","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2018.07.035_b0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1932296816658900","article-title":"Changes in HbA1c and weight following transition to continuous subcutaneous insulin infusion therapy in adults with type 1 diabetes","volume":"11","author":"Mehta","year":"2017","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.diabres.2018.07.035_b0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcjd.2013.08.268","article-title":"Lifestyle and cardiometabolic risk in adults with type 1 diabetes: a review","volume":"38","author":"Leroux","year":"2014","journal-title":"Can J Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2018.07.035_b0110","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/193229681200600429","article-title":"Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion","volume":"6","author":"Heinemann","year":"2012","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.diabres.2018.07.035_b0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/js960297s","article-title":"Toward understanding insulin fibrillation","volume":"86","author":"Brange","year":"1997","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.diabres.2018.07.035_b0120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/193229680800200314","article-title":"Laboratory-based non-clinical comparison of occlusion rates using three rapid-acting insulin analogs in continuous subcutaneous insulin infusion catheters using low flow rates","volume":"2","author":"Kerr","year":"2008","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.diabres.2018.07.035_b0125","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1177\/193229681300700620","article-title":"Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review","volume":"7","author":"Kerr","year":"2013","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"10.1016\/j.diabres.2018.07.035_b0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1089\/dia.2015.0342","article-title":"Reduced Silent occlusions with a novel catheter infusion set (BD FlowSmart): results from two open-label comparative studies","volume":"18","author":"Gibney","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.diabres.2018.07.035_b0135","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1089\/dia.2018.0110","article-title":"Duration of catheter use in patients with diabetes using continuous subcutaneous insulin infusion: A review","volume":"20","author":"Bonato","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.diabres.2018.07.035_b0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-2007-970593","article-title":"Seeking the factors predisposing to local skin inflammatory state development in children with type 1 diabetes (T1DM) treated with continuous subcutaneous insulin infusion (CSII)","volume":"115","author":"Jarosz-Chobot","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"10.1016\/j.diabres.2018.07.035_b0145","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jpeds.2007.10.006","article-title":"Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents","volume":"152","author":"Conwell","year":"2008","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.diabres.2018.07.035_b0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13300-016-0187-6","article-title":"Group A-OITS. Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is Clear?","volume":"7","author":"Gentile","year":"2016","journal-title":"Diabetes Ther"},{"issue":"4","key":"10.1016\/j.diabres.2018.07.035_b0155","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/1932296815622647","article-title":"CSII: longer catheter usage time, a reasonable goal","volume":"10","author":"Ardilouze","year":"2016","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.diabres.2018.07.035_b0160","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1177\/1932296815604438","article-title":"Using insulin infusion sets in CSII for longer than the recommended usage time leads to a high risk for adverse events: results from a prospective randomized crossover study","volume":"9","author":"Pfutzner","year":"2015","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/j.diabres.2018.07.035_b0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jdiacomp.2009.03.002","article-title":"Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion","volume":"24","author":"Thethi","year":"2010","journal-title":"J Diabetes Complicat"},{"issue":"4","key":"10.1016\/j.diabres.2018.07.035_b0170","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/193229681000400429","article-title":"Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3","volume":"4","author":"Schmid","year":"2010","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"10.1016\/j.diabres.2018.07.035_b0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/dia.2015.0432","article-title":"Duration of infusion set survival in lipohypertrophy versus nonlipohypertrophied tissue in patients with type 1 diabetes","volume":"18","author":"Karlin","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2018.07.035_b0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/dia.2013.0119","article-title":"Randomized trial of infusion set function: steel versus teflon","volume":"16","author":"Patel","year":"2014","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"10.1016\/j.diabres.2018.07.035_b0185","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1464-5491.2002.00713.x","article-title":"Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years","volume":"19","author":"Linkeschova","year":"2002","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.diabres.2018.07.035_b0190","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2018.07.035_b0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1464-5491.2007.02346.x","article-title":"Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections","volume":"25","author":"Nicolucci","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2018.07.035_b0200","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.diabres.2017.02.022","article-title":"Practices, perceptions and expectations for carbohydrate counting in patients with type 1 diabetes \u2013 Results from an online survey","volume":"126","author":"Fortin","year":"2017","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822718303991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822718303991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T17:43:23Z","timestamp":1661708603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822718303991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":40,"alternative-id":["S0168822718303991"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2018.07.035","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2018.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}